The multiple preclinical studies have shown that SOX2 knockdown mediated by siRNAs, shRNAs or miRNAs dramatically suppresses proliferation and invasion of cancer cells in both in vitro cell culture and in vivo xenograft tumor models (Huser et al., 2018). Here, SOX2 is linked to neoplasm.